IntuitiveX

What IntuitiveX does

IntuitiveX is a Seattle-based private healthcare innovation incubator and consultancy founded in March 2016 by Dr. Jeffrey Roh (CEO), Simon Robinson (Chief IP Officer), and Mark Han (President and Chief Legal Officer). The company operates a closed-loop model that combines IP creation and monetization with commercialization services for medical device, digital health, biotech, and pharmaceutical ventures. Its core service offerings include FDA regulatory guidance, competitive market analysis, IP patent landscaping and licensing, product development, fundraising support, executive recruiting, and strategic partnership facilitation. The proprietary IP engine, branded as IX Innovation, leverages white space analysis and surgical expertise to file and monetize IP assets across surgical robotics, AI-driven surgical systems, telesurgery, and adjacent therapeutic areas.

The company manages 12+ portfolio companies spanning real-time surgical intelligence (IX MedSolutions), FDA-cleared electrical muscle stimulation (Neuro20 PRO System), cannabis and psychedelic therapeutic IP (Green Sky Creations), healthcare price transparency software (Transpara Health), and a deep spine/orthopedic device pipeline including AltPep, Amplify Surgical, Auctus Surgical, Carlsmed, Chiral Surgical, Cortical Dynamics, DigiPrep, Navlab, and Novapproach Spine. IntuitiveX claims $300M+ in value created for shareholders, $120M+ in capital raised for portfolio companies, and 100+ IP assets under management, with three portfolio companies holding FDA Breakthrough Device Designations.

The revenue model spans professional consulting fees, IP development fees, licensing/royalties, and equity stakes in incubated companies. Distribution is direct-to-client via enterprise field sales to venture funds, corporate innovation arms, startups, and growth-stage healthcare companies. The company commercializes ventures globally from its Seattle headquarters and reports active engagement across the United States, Korea (via KOSME), Canada (via OBIO), and Australia (via Cortical Dynamics). Strategic advisors and board members include former executives of Stryker, Medtronic, NuVasive, Intellectual Ventures, IBM, Microsoft Healthcare, and KPMG, alongside former Washington State Governor Gary Locke.

Name

IntuitiveX

Legal name

IntuitiveX

Website

https://intuitivex.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

IntuitiveX is a Seattle-based healthcare innovation incubator and consultancy that creates, patents, and monetizes medical IP while providing commercialization, regulatory, and fundraising services across digital health, biotech, pharma, and medical devices.

Ownership category

akta.pro rank

Product category

Healthcare Innovation Consulting & Medical Device Incubation

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Custom Computer Programming Services (541511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Management Consulting Services (8742), Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Customer Experience (CX) & Digital Experience (BPAHAEAC)

akta.pro secondary industry

Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)

Keywords

• Healthcare innovation consulting
• Medical device incubation
• Intellectual property services
• Medtech commercialization advisory
• Biotech startup acceleration

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. IP Creation and Monetization: Creating, patenting, spinning out, and monetizing intellectual property across healthcare and life sciences sector through proprietary IP engine combining white space analysis with surgical expertise
2. Consulting Services: One-stop-shop consulting service offering IP development, commercialization, corporate development, regulatory approval processes, and product market introduction
3. Portfolio Company Equity: Acquiring equity stakes in early-stage emerging technology medical companies through closed-loop incubation model

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

IntuitiveX is a healthcare innovation incubator and consultancy that de-risks and commercializes early-stage medical technologies through a closed-loop incubation model. It provides MedTech & Life Sciences Commercialization consulting (regulatory pathways, competitive analysis, fundraising, product development, marketing, executive recruiting) and Intellectual Property Services (patent landscaping, IP licensing, provisional and utility filings, invention on demand). The firm also creates, patents, spins out, and monetizes IP in digital health, biotech, pharma, and medical devices via a portfolio of more than 12 portfolio companies.

Product overview

IntuitiveX is a healthcare innovation incubator and consultancy with two primary service divisions: MedTech & Life Sciences Commercialization and Intellectual Property Services. The MedTech & Life Sciences Commercialization division provides regulatory guidance, competitive market analysis, advisory recruiting, incorporation, product development, strategic partnerships, marketing, fundraising, software development, executive recruiting, and bookkeeping services. The Intellectual Property Services division covers patent landscaping, IP licensing, provisional and utility application filing, invention on demand, and IP patentability assessments. The company manages a portfolio of 14+ healthcare companies including IX MedSolutions (real-time surgical intelligence platform), IX Innovation (IP creation and monetization engine), Neuro20 PRO System (FDA-cleared whole-body electrical muscle stimulation), Green Sky Creations (cannabis/psychedelic therapeutics IP), Transpara Health (healthcare price transparency), and nine medical device portfolio companies (AltPep, Amplify Surgical, Auctus Surgical, Carlsmed, Chiral Surgical, Cortical Dynamics, DigiPrep, Navlab, Novapproach Spine). The company operates globally with offices in Seattle, Washington, leveraging a clinical network of 200+ specialists across digital health, biotech, pharma, and medical devices. Value created for shareholders: $300M+; capital raised for portfolio companies: $120M+; IP assets managed: 100+; FDA Breakthrough Device Designated Companies: 3.

Differentiator

Problem solved

Functional benefit

Products and services

• MedTech & Life Sciences Commercialization One-stop-shop consulting service offering regulatory guidance across FDA pathways, competitive market analysis, advisory recruiting, incorporation support, product development (prototyping, testing, validation), strategic partnership identification, full marketing services, governing documents and shareholder agreements, fundraising support (seed to VC), software development, executive recruiting, and bookkeeping/accounting for medical device and life sciences companies.
• Intellectual Property Services Comprehensive IP service covering patent landscaping, IP licensing, provisional application preparation and filing, invention on demand, utility application filing, divisional applications, IP patentability assessments, and continuation application preparation and filing for healthcare and life sciences clients.
• IX MedSolutions Real-Time Surgical Intelligence Platform Sensor-enabled surgical intelligence platform that captures pressure, motion, and usage patterns from traditional surgical tools and delivers AI-powered live intraoperative feedback, decision support, and complication alerts. Integrates with EHR and hospital infrastructure for surgical workflow, documentation, and postoperative care. For hospitals and surgical teams.
• IX Innovation (IP Creation and Monetization Engine) Proprietary IP creation and monetization engine covering surgical robotics, AI for surgical systems, and telesurgery. Uses white space analysis and corporate landscaping to create and monetize medical technology IP through sales, licensing, or startup creation. Filed more than 30 IP assets in its first year.
• Neuro20 PRO System FDA-cleared whole-body electrical muscle stimulation system using a wire-free, whole-body Lycra smart suit targeting 42+ muscles. Indicated for muscle spasm relaxation, range of motion enhancement, prevention of muscle atrophy, improvement of local blood circulation, muscle strength enhancement, and recovery from impaired muscle function.
• Green Sky Creations Technology and IP development company for cannabis- and psychedelic-centric therapeutic and wellness products. Holds 7 patents covering active beverage containers, flavored vape devices, controlled psychoactive substance administration during sleep, and multi-stage dosage formats for cannabinoids.
• Transpara Health Software solution that enables healthcare price transparency and provider data transparency. Helps patients navigate the healthcare system by providing full transparency to pricing, relevant data, and provider backgrounds before committing to appointments, automating search and matching with healthcare professionals based on criteria.
• Novapproach Spine Developing novel anterior approaches and implants for anterior lumbar spine surgery (ALIF). The patent-pending technique enables reaching all lumbar spinal levels without long incisions or patient position changes during surgery.
• AltPep Peptide-based platform tackling amyloid diseases through early diagnostics, disease-modifying therapeutics, and anti-biofilm treatments. Discovered the alpha-sheet protein structure for targeting toxic amyloid species. Received FDA Breakthrough Device Designation and raised over $23.1M in Series A financing.
• Amplify Surgical Spinal implant company focused on outpatient spinal fusions with minimally invasive, endoscopic surgical solutions. Developed dualX, a dual expanding interbody fusion system. FDA-approved; completed 1,400+ surgical cases across 85+ hospitals in 35+ states.
• Auctus Surgical Dynamic spinal tethering systems for non-fusion scoliosis correction using magnetically driven non-surgical adjustment. Also developing a magnetically growing intramedullary rod for limb lengthening.
• Carlsmed (PACC Platform) AI and predictive analytics platform (PACC) for personalizing treatment of complex adult spinal deformities. Creates patient-specific and surgical plan-specific cages and instrumentation plans by analyzing prior patient outcomes and imaging data. FDA Breakthrough Device Designation and NTAP reimbursement. Has raised $12.5M in financing.
• Cortical Dynamics (BARM Brain Function Monitor) Brain Anaesthesia Response Monitor (BARM) - next generation brain function monitoring system providing reliable objective measure of anesthetic state during surgery or sedation in the ICU using Composite Cortical State (CCS) and Cortical Input (CI) measures.
• DigiPrep Digital Tooth Preparation System World's first completely digital tooth preparation solution for dental restorations, with a fully patented process utilizing intra-oral scanning, CAD/CAM design, and milling/printing. Improves accuracy and reduces chair time for dental procedures.
• Navlab Surgical Navigation Strategic IP development company for surgical navigation using AI and AR/VR technology for surgical planning and intraoperative assistance. Operates a 12-asset IP portfolio covering surgical workflow, AR/VR tools, AI for surgical systems, and surgical navigation.

Quantifiable outcome

• $300M+ in value created for shareholders
• +5 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability13 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• University of Washington CoMotioncoreStrategic or Co-development PartnerPartnership to launch a bio+healthcare accelerator program with KOSME and Washington Technology Industry Association. Secured $250,000 contract for program launch.
• Washington Technology Industry AssociationcoreStrategic or Co-development PartnerPartnership alongside University of Washington CoMotion and KOSME to launch a bio+healthcare accelerator program for Korean startups.
• Major MedTech and Robotics CompaniescoreStrategic or Co-development PartnerEstablished relationships with all major spine and robotics companies, three of which have purchased IP assets from Navlab and IX Innovation. Considered as partners moving forward for IP monetization.
• ipCapital GroupcoreStrategic or Co-development PartnerStrategic advisor John Cronin serves as Managing Director and Chairman of ipCapital Group. ipCG has worked with over 1000 companies and provides IP consulting expertise.
• Cortical DynamicsminorStrategic or Co-development PartnerAustralian medical device company with Brain Anaesthesia Response Monitor (BARM) technology - portfolio company with IP and commercialization support relationship.
• CTL AmedicaminorStrategic or Co-development PartnerAcquired Chiral Surgical, demonstrating successful exit and ongoing relationship with major medtech acquirer.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Alexandria LaunchLabs: Alexandria Real Estate's life sciences incubator providing capital, lab space, and strategic guidance to early-stage therapeutics, diagnostics, and medtech companies. Comparable to IntuitiveX's incubation model with a focus on real estate-anchored company formation in life sciences.
• IndieBio (SOSV): Biotech accelerator providing seed funding, lab space, and mentorship to science-based startups across therapeutics, diagnostics, and biology. Comparable to IntuitiveX's biotech portfolio support and IP commercialization play, especially for companies like AltPep.
• Fogarty Innovation: Medical device incubator and educational nonprofit providing startups with clinical and commercialization mentorship, IP guidance, and industry introductions. Highly comparable to IntuitiveX's medtech focus, regulatory expertise, and IP-driven value capture for portfolio companies like Amplify Surgical, Carlsmed, and Auctus.
• Bolt: Hardware-focused accelerator supporting medical device, robotics, and connected hardware startups with prototyping resources and commercialization support. Comparable to IntuitiveX's medical device and surgical robotics portfolio (Navlab, Amplify Surgical, Auctus Surgical).
• MATTER: Chicago-based healthcare incubator and accelerator supporting medical device, biotech, and digital health startups through mentorship, corporate partnerships, and commercialization resources. Directly comparable to IntuitiveX as a healthcare-focused startup catalyst with consulting and incubation services.
• Cedars-Sinai Accelerator: Hospital-affiliated healthcare accelerator focused on medical devices, digital health, and biotech, providing clinical validation and commercialization support to startups. Directly comparable to IntuitiveX's healthcare commercialization services and clinical network of 200+ innovators.
• UCSF Rosenman Institute: Health technology accelerator affiliated with UCSF that supports medical device, digital health, and biotech founders with clinical validation, mentorship, and industry connections. Comparable to IntuitiveX's clinical network model and healthcare commercialization services.

Emerging players

• StartX Med: Stanford-affiliated startup accelerator with a medical vertical providing mentorship, IP guidance, and commercialization support to early-stage healthcare companies. Comparable to IntuitiveX's incubation model with academic roots and access to clinical/research networks.
• Rock Health: Digital health venture fund and advisory firm supporting early-stage healthcare technology companies with capital, strategic partnerships, and industry research. Comparable to IntuitiveX's digital health portfolio and consulting services, with a sharper focus on software-driven healthcare rather than hardware/devices.

Broad incumbents

• Johnson & Johnson Innovation (JLABS): Johnson & Johnson's healthcare-focused incubator network offering lab space, mentorship, and commercialization support to early-stage medtech, biotech, and digital health startups. Most directly comparable to IntuitiveX as a healthcare innovation incubator, but operates at significantly larger scale with deeper balance sheet.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/IntuitiveXinc
• Facebookfacebook.com/IntuitiveX
• LinkedInlinkedin.com/company/intuitivex
• Instagraminstagram.com/intuitivex.inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IntuitiveX